Replies to post #205073 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

Hard to argue a position based on subjective personal observation.

** drops mic **

[seventhwave]

No one on this board expects MMSE/ADCS-ADL to remain unchanged or increase over time for A2-73 patients. Period. The bar is low as no current treatment has been able to decelerate the natural rate of decline in patients. You're assertions reveal a questionable grasp of the issues related to trial outcome.